Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Hydrochlorothiazide
- Therapeutic area
- Cardiovascular
- Drug class
- Diuretics
- ATC
- C03
- Strength
- 80 mg
- Dosage form
- Tablet
- Pack
- 28’s
- Registration no.
- 082436
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-11 02:59
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What C-Val Plus (Hydrochlorothiazide) is used for
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Hydrochlorothiazide is right for you and the dose.
- High blood pressure (hypertension): a first-choice medicine that helps the kidneys remove extra salt and water
- Kidney stones: chosen by stone type and urine tests for people at high risk: a thiazide diuretic for too much calcium in the urine, allopurinol for too much uric acid in the urine, and alkalinising medicines (which make urine less acidic) for uric acid or cystine stones or low citrate
About C-Val Plus 80 mg tablet
C-Val Plus 80 mg tablet contains Hydrochlorothiazide 80 mg. It is registered with DRAP by CRYSTOLITE PHARMACEUTICALS (registration no. 082436). Its official price is PKR 677.14 for a pack of 28’s, about PKR 24.18 per tablet. This price has applied since 27 August 2025. C-Val Plus is also available as 12.5 mg + 160 mg tablet. 1 other brand of Hydrochlorothiazide 80 mg (tablet) is registered in Pakistan. Compare all brands and prices →
Other strengths of C-Val Plus
All 1 other brands of Hydrochlorothiazide 80 mg tablet in Pakistan
These 1 brands are alternatives (substitutes) to C-Val Plus: each contains Hydrochlorothiazide 80 mg tablet. Ask your doctor or pharmacist before you switch brands.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Nuval-D | PHARMEVO (PVT) LTD | 2 x 7's | PKR 364.28 | PKR 26.02 / tablet |
How old is this price? It was fixed on 27 August 2025 and has not changed since — that is 14 months ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for C-Val Plus, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- CRYSTOLITE PHARMACEUTICALS, Islamabad
- DRAP registration
- 082436
- Phone
- +92 342 0022555
- info@crystolite.com.pk
- Website
- https://crystolite.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (28’s). Current price PKR 677.14, effective 27 Aug 2025.
Cite this price history
MedInfoBase. C-Val Plus 80 mg, 28’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/c-val-plus-80-mg-082436-28s-crystolite-pharmaceuticals/ (accessed 11 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 677.14 | 2025-08-27 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 082436Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.